您当前所在的位置:首页 > 产品中心 > 产品信息
PD318088_分子结构_CAS_391210-00-7)
点击图片或这里关闭

PD318088

产品号 S1568 公司名称 Selleck Chemicals
CAS号 391210-00-7 公司网站 http://www.selleckchem.com
分子式 C16H13BrF3IN2O4 电 话 (877) 796-6397
分子量 561.0890996 传 真 (832) 582-8590
纯 度 电子邮件 sales@selleckchem.com
保 存 -20°C Chembase数据库ID: 72748

产品价格信息

请登录

产品别名

标题
PD318088
IUPAC标准名
5-bromo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
IUPAC传统名
C16H13BrF3IN2O4

产品登记号

CAS号 391210-00-7

产品性质

作用靶点 MEK
成盐信息 Free Base
保存条件 -20°C

产品详细信息

详细说明 (English)
Research Area
Description Cancer
Biological Activity
Description PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor.
Targets MEK1/2
IC50
In Vitro PD318088 is a small-molecule inhibitor of MEK1/2, which is an analog of PD184352, suggesting it might have substantial anti-proliferative activity against cancer cells, although no functional study of PD318088 is currently available. PD318088 binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site. Formation of the ternary complexes with PD318088 and MgATP results in moderate increases (to 140 nM) for the Kd monomer-dimer for both MEK1 and MEK2. The binding of PD318088 and MgATP to MEK1 also abolishes the formation of tetramers and higher-order aggregates. PD318088 and MgATP together increase the dimerization disassociation constant for MEK1 and MEK2 slightly from ~75 nM to ~140 nM, suggesting that the mechanism of inhibition for PD318088 is probably a result of localized conformational changes in the active site and not a global change in the overall structure. [1]
In Vivo
Clinical Trials
Features
References
[1] Ohren JF, et al. Nat Struct Mol Biol, 2004, 11(12), 1192-1197.